Self-Delivery Photodynamic Nanoinhibitors for Tumor Targeted Therapy and Metastasis Inhibition

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Cancer Therapy

Background:

• Photodynamic therapy (PDT) shows promise for primary tumors but can worsen hypoxia, reducing efficacy and promoting metastasis.
• Simultaneous inhibition of primary tumor growth and metastasis is crucial for improving cancer patient survival rates.

Purpose of the Study:

• To develop self-delivery photodynamic nanoinhibitors (PNI) for targeted cancer therapy and metastasis inhibition.
• To overcome the limitations of traditional PDT, including hypoxia exacerbation and reduced therapeutic efficacy.

Main Methods:

• PNI were designed using a carbonic anhydrase inhibitor (CAi), a poly(ethylene glycol) (PEG) linker, and protoporphyrin IX (PpIX) photosensitizer.
• The self-delivery system ensures targeted delivery and synergistic action of CAi and PpIX, avoiding premature release.
• PNI selectively inhibit tumor-associated carbonic anhydrase IX (CA IX), addressing hypoxia-induced signaling and PDT resistance.

Main Results:

• The self-delivery design of PNI enhanced the availability and synergism of CAi and PpIX.
• CA IX inhibition by PNI facilitated targeted drug delivery and modulated hypoxia-related signaling pathways.
• PNI demonstrated significant inhibition of both primary tumor growth and distant metastasis.

Conclusions:

• PNI represent a novel strategy for overcoming the defects of traditional PDT by combining targeted inhibition of CA IX and PDT.
• This targeted self-delivery approach offers a promising avenue for improving cancer treatment outcomes by addressing both primary tumors and metastasis.